DR. CHRISTOPHER ANTHONY WAYNICK M.D. NPI 1780819375

NPI Information

  • NPI: 1780819375
  • Provider Name: DR. CHRISTOPHER ANTHONY WAYNICK, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 1840 MEDICAL CENTER PKWY
    SUITE 300
    MURFREESBORO, TN
    ZIP 37129
  • Phone: (615) 848-0488

Map and Directions

Get Directions

NPI Details

DR. Christopher Anthony Waynick, M.D. is a hematology and oncology internal medicine in Murfreesboro, TN with 17 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Christopher Anthony Waynick, M.D. NPI is 1780819375. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TENNESSEE, HSC, COLLEGE OF MEDICINE
Graduation Year:2009

The provider's business location address is:

1840 MEDICAL CENTER PKWY
SUITE 300
MURFREESBORO, TN
ZIP 37129-199
Phone: (615) 848-0488
Fax: (615) 904-9061

The NPI 1780819375 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Measurement of immunoglobulin light chains (HCPCS:83521)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
  • Protein measurement, serum (HCPCS:84165)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Folic acid level, serum (HCPCS:82746)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Magnesium level (HCPCS:83735)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
  • Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Uric acid level, blood (HCPCS:84550)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Automated urinalysis test (HCPCS:81003)
  • Phosphate level (HCPCS:84100)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Erythropoietin (protein) level (HCPCS:82668)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Cortisol (hormone) measurement, total (HCPCS:82533)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Red blood count, automated test (HCPCS:85045)
  • Haptoglobin (serum protein) level (HCPCS:83010)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Application of on-body injector for under skin injection (HCPCS:96377)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Red blood cell sedimentation rate, to detect inflammation, automated (HCPCS:85652)

The enumeration date for this NPI number is 5/26/2009 and was last updated on 7/8/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology54310TENNESSEEYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.